Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer
| Autor: | Gordon, Alan N. *, Tonda, Margaret, Sun, Steven, Rackoff, Wayne |
|---|---|
| Zdroj: | In Gynecologic Oncology October 2004 95(1):1-8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect